Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.
Metronomic chemotherapy using the 5-FU prodrug uracil-tegafur (UFT) and cyclophosphamide (CTX) was previously shown to only modestly delay primary tumor growth, but nevertheless markedly suppressed the development of micro-metastasis in an orthotopic breast cancer xenograft model, using the metastat...
Main Authors: | Raquel Muñoz, Denise Hileeto, William Cruz-Muñoz, Geoffrey A Wood, Ping Xu, Shan Man, Alicia Viloria-Petit, Robert S Kerbel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0222580 |
Similar Items
-
Impact of Metronomic UFT/Cyclophosphamide Chemotherapy and Antiangiogenic Drug Assessed in a New Preclinical Model of Locally Advanced Orthotopic Hepatocellular Carcinoma
by: Terence C. Tang, et al.
Published: (2010-03-01) -
Development of a Resistance-like Phenotype to Sorafenib by Human Hepatocellular Carcinoma Cells Is Reversible and Can Be Delayed by Metronomic UFT Chemotherapy
by: Terence C. Tang, et al.
Published: (2010-11-01) -
Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide
by: Urban Emmenegger, et al.
Published: (2011-01-01) -
Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers
by: Luana Schito, et al.
Published: (2020-09-01) -
Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
by: Raquel Muñoz, et al.
Published: (2021-10-01)